NENational nstitute forHealth and Care ExcellenceNICE贝guidanceOlaparib for previouslytreated BRCA mutation-positive hormone-relapsedmetastatic prostate cancerTechnology appraisal guidancePublished:10 May 2023www.nice.org.uk/quidance/ta887NICE 2023.All rights reserved.Subject to Notice of rights (https://www.nice.org.uk/temms-and-conditions#notice-of-rights).